| Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis GA Block, KJ Martin, ALM De Francisco, SA Turner, MM Avram, ... New England Journal of Medicine 350 (15), 1516-1525, 2004 | 1419 | 2004 |
| Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial D De Zeeuw, R Agarwal, M Amdahl, P Audhya, D Coyne, T Garimella, ... The Lancet 376 (9752), 1543-1551, 2010 | 903 | 2010 |
| Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States R Agarwal, AR Nissenson, D Batlle, DW Coyne, JR Trout, DG Warnock The American journal of medicine 115 (4), 291-297, 2003 | 744 | 2003 |
| Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients’ Response to IV … DW Coyne, T Kapoian, W Suki, AK Singh, JE Moran, NV Dahl, AR Rizkala, ... Journal of the American Society of Nephrology 18 (3), 975-984, 2007 | 524 | 2007 |
| Increased plasma leptin concentration in end-stage renal disease E Merabet, S Dagogo-Jack, DW Coyne, S Klein, JV Santiago, SP Hmiel, ... The journal of clinical endocrinology & metabolism 82 (3), 847-850, 1997 | 393 | 1997 |
| Impact of dialysis dose and membrane on infection-related hospitalization and death: results of the HEMO Study M Allon, TA Depner, M Radeva, J Bailey, S Beddhu, D Butterly, ... Journal of the American Society of Nephrology 14 (7), 1863-1870, 2003 | 292 | 2003 |
| Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD D Coyne, M Acharya, P Qiu, H Abboud, D Batlle, S Rosansky, S Fadem, ... American Journal of Kidney Diseases 47 (2), 263-276, 2006 | 289 | 2006 |
| Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran B Michael, DW Coyne, S Fishbane, V Folkert, R Lynn, AR Nissenson, ... Kidney international 61 (5), 1830-1839, 2002 | 266 | 2002 |
| Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference IC Macdougall, AJ Bircher, KU Eckardt, GT Obrador, CA Pollock, ... Kidney international 89 (1), 28-39, 2016 | 256 | 2016 |
| Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients G Saab, DO Young, Y Gincherman, K Giles, K Norwood, DW Coyne Nephron Clinical Practice 105 (3), c132-c138, 2007 | 224 | 2007 |
| Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients R Provenzano, B Schiller, M Rao, D Coyne, L Brenner, BJG Pereira Clinical Journal of the American Society of Nephrology 4 (2), 386-393, 2009 | 214 | 2009 |
| Ferric gluconate reduces epoetin requirements in hemodialysis patients with elevated ferritin T Kapoian, NB O'Mara, AK Singh, J Moran, AR Rizkala, R Geronemus, ... Journal of the American Society of Nephrology 19 (2), 372-379, 2008 | 194 | 2008 |
| Iron supplementation to treat anemia in patients with chronic kidney disease A Besarab, DW Coyne Nature Reviews Nephrology 6 (12), 699-710, 2010 | 193 | 2010 |
| Vitamin D deficiency and anemia in early chronic kidney disease NM Patel, OM Gutiérrez, DL Andress, DW Coyne, A Levin, M Wolf Kidney international 77 (8), 715-720, 2010 | 188 | 2010 |
| Upper extremity central venous obstruction in hemodialysis patients: treatment with Wallstents. TM Vesely, DM Hovsepian, TK Pilgram, DW Coyne, S Shenoy Radiology 204 (2), 343-348, 1997 | 175 | 1997 |
| Hepcidin: clinical utility as a diagnostic tool and therapeutic target DW Coyne Kidney international 80 (3), 240-244, 2011 | 167 | 2011 |
| A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients SC Cheng, DO Young, Y Huang, JA Delmez, DW Coyne Clinical Journal of the American Society of Nephrology 3 (4), 1131-1138, 2008 | 153 | 2008 |
| An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism. HH Malluche, MC Monier-Faugere, G Wang, OJM Frazã, C Charytan, ... Clinical nephrology 69 (4), 269-278, 2008 | 149 | 2008 |
| Regulation of mesangial cell cyclooxygenase synthesis by cytokines and glucocorticoids DW Coyne, M Nickols, W Bertrand, AR Morrison American Journal of Physiology-Renal Physiology 263 (1), F97-F102, 1992 | 135 | 1992 |
| Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation AK Singh, DW Coyne, W Shapiro, AR Rizkala, DRIVE Study Group Kidney international 71 (11), 1163-1171, 2007 | 132 | 2007 |
